ArticlePain2025
Cortical astrocyte activation triggers meningeal nociception and migraine-like pain.
Article in Pain, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Non-neuronal targets for migraine therapy.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026Review
- Targeting glial-orchestrated neuroinflammation in migraine pathophysiology.The journal of headache and pain · 2026Review
Corrections and comments
- Update of
Authors and funding
4 authors.
Funding
Abstract
abstractCortical astrocytes were implicated in migraine attacks involving cortical spreading depolarizations and related aura symptoms. However, whether the activation of cortical astrocytes is sufficient to generate migraine headaches is unknown. We investigated the role of cortical astrocytes in migraine pain triggering using a DREADD-based chemogenetic approach to activate visual cortex astrocytes, assessing its effect on the responses of meningeal nociceptors, the development of migraine-like behaviors, and their dependence on peripheral CGRP signaling. In a rat model, activating cortical astrocytes was sufficient to induce prolonged ongoing discharge and mechanical sensitization of meningeal nociceptors. Cortical astrocytic activation also generated cephalic mechanical pain hypersensitivity, reduced exploratory behavior, and anxiety-like behaviors linked to migraine headaches. Blocking CGRP signaling with a monoclonal antibody suppressed astrocyte-driven meningeal nociceptor discharge and alleviated migraine-related behaviors. We propose that augmented activation of visual cortex astrocytes during cortical hyperexcitability events in migraine attacks with and without aura is sufficient to trigger meningeal nociception and the ensuing migraine pain. Our findings could aid the development of novel effective migraine treatments.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.